Summary. The effects of dietary supplementation with granulated guar gum (21 g/day in three divided doses at the main meals), were compared with placebo response during three months in a doubleblind, cross-over trial in 11 Type 2 (insulin-independent) diabetics. The nine patients who completed the study (two dropped out because of side-effects) showed a significant reduction in both basal and postprandial hyperglycaemia as well as of urinary excretion of glucose during guar gum supplementation. No change in mean bodyweight was observed during the study. Mean fasting and post-prandial plasma insulin levels were similar during both study periods, but the two subjects who received no oral hypoglycaemic agents had lower insulin levels during the guar gum period. Mean serum total-and LDL-cholesterol concentrations were significantly lower during the guar gum period, whereas the HDL-cholesterol level remained unchanged. Long-term administration of guar gum induced a sustained improvement in diabetic control in Type 2 diabetes.
Dietary fibre has marked effects on blood glucose concentration in both normal subjects and diabetics. Post-prandial hyperglycaemia is reduced when meals are enriched with guar gum [1, 2] , by consumption of high-carbohydrate, high-fibre diets [3, 4] , or with diets rich in dietary fibre [5, 6] . Cereal fibre has been less effective [7] .
The reduction of post-prandial hyperglycaemia, induced by gel-forming fibre, seems mainly to depend on delayed gastric emptying [8] and not on impaired absorption of carbohydrates [7] . In longterm studies a sustained improvement in the control of diabetes for periods of weeks or months has been observed [3, 9, 10] , and a prolonged effect of a single dose of guar gum has been demonstrated [11] . These findings suggest that factors other than the effect on gastric emptying may be involved.
In order to elucidate the long-term effects of gelforming fibre in diabetes, we have performed a controlled study on the effects of a 3 month dietary supplementation with guar gum on glucose and lipid metabolism in a group of subjects with type 2 (insulin-independent) diabetes.
Materials and Methods

Subjects
Eleven insulin-independent diabetics were studied. Two of these dropped out because of side-effects. The nine subjects who completed the study (five males and four females) had a mean age of 53 years (range 39-69 years) and a mean duration of diabetes of 6.5 years (range 1-15 years). The mean relative bodyweight was 116% of ideal weight (Metropolitan Life Insurance Tables), and only two subjects were more than 20% overweight. Of the subjects, two were treated with diet only, while seven were on treatment with the sulphonylurea derivative glibenclamide, 10-15 mg/ day. The drug therapy was kept constant throughout the study. Informed consent was obtained from each subject prior to the beginning of the study. Approval for the study had been given by the Ethical Committee of the University of Kuopio.
Experimental Design
A double-blind, cross-over trial designed to include two successive 3 month periods during which the diet was supplemented either with 21 g of guar gum or placebo.
A granulated, slow-gelling guar gum preparation was used (Guarem®, Remeda Pharmaceuticals, Kuopio, Finland). The 0012-186X/81/0021/0029/$Ol.00 
Results
Bodyweight
The mean bodyweight of the nine subjects who completed the study was 70.7 kg after the guar gum period and 70.2 kg after the placebo period. The largest individual fluctuations were an increase of 1.7 and a decrease of 3 kg during guar gum and an increase of 2.8 and a decrease of 3 kg during the control period.
granules are prepared using ethyl cellulose and gelatin spirit, dried at + 50°C. Their diameter is less than 2.5 mm. The placebo preparation consisted of similarly prepared wheat flour (0.3 MJ = 75 kcal, and 0.7 g of dietary fibre/21 g). The subjects were given one sachet of 7 g of the granules with the three main meals. This was mixed with 2 dl of fluid, and ingested within 1-2 min at the beginning of meals. No diet records were obtained, but subjects were advised not to change their dietary habits during the study. Their previous dietary instructions recommended 50% of energy from carbohydrates, 20% from proteins, and 30% from fats. The order of the preparations was determined randomly: five of the subjects started with guar gum and four with placebo.
Bodyweight, blood glucose concentration and 24-h urinary glucose excretion were determined at the beginning of the study and after one, two and three months of each test period. Serum lipids and serum and urinary calcium were estimated at the beginning and after three months of each period. The side-effects were registered monthly.
On the last day of each three-month period the subjects were admitted to hospital for one test-day during which they were given a standard diet of 5.9 MJ (1,400 kcal), supplying 55% of the energy as carbohydrates, 15% as proteins, and 30% as fats. The breakfast and the evening snack yielded 1.2 MJ (280 kcal) and the lunch and the dinner 1.8 MJ (420 kcal) each. The guar gum and the placebo granules were administered at the beginning of breakfast, lunch and dinner. The lunch was composed of 40 g chicken, 120 g potatoes, 40 g wholemeal rye-bread, 11 g butter, 80 g carrots, 30 g lettuce, 10 g paprika, 10 g cucumber and a pudding made of 20 g cowberries and 7 g hulled wheat. The meal was ingested within 20 min. Blood samples were obtained for determination of blood glucose and plasma insulin before breakfast (after a 12-h fast), before lunch and 15, 30, 45, 60, 90, and 120 min after lunch ended, and before and 1 h after the end of the evening snack. The subjects took their usual drugs including the sulphonylureas.
Assays
Glucose was assayed by the glucose oxidase method Glox (Kabi Ab, Sweden) and insulin by radioimmunoassay RIA-Gnost (Behringwerke, West Germany). Serum lipoproteins were separated by ultracentrifugation at d 1.006, followed by precipitation of the bottom fraction by dextran sulphate and MgCl 2 [12] . Enzymatic methods were used for the determination of cholesterol [13] and triglycerides [14] . Calcium from the serum was assayed by
Blood and Urinary Glucose
At the beginning of the study, the fasting blood glucose concentration was 10.6 ± 0.9 mmolll (range 6.8-14.4 mmolll) and the 24-h excretion of glucose 30.3 ± 17.5 g (range 0-166 g).
The fasting blood glucose level was lower during guar gum supplementation throughout the threemonth period and, concomitantly, the mean glucose excretion was markedly reduced ( Table 1 ). The mean blood glucose level of the subjects who started on guar gum was 9.4 mmolll before the study, 9.4 mmolll after guar gum, and 11.1 mmolll after placebo. In those who started on placebo, it was 11.5 mmolll before the study, 13.5 mmolll after placebo, and 10.7 mmolll after guar gum. The smaller glucose excretion after one month on placebo (Table 1) is due to a carry-over effect in the group which started on guar gum showing a mean glucose excretion of 19 g after one month, and of 40 g after three months on placebo.
During the test-day at hospital, both the fasting and the post-prandial blood glucose levels were significantly lower during guar gum as compared with the control period (Fig. 1) . The post-prandial increment of blood glucose was slightly less when guar gum was consumed but the difference to the control period was not statistically significant. During guar gum supplementation, the blood glucose levels were significantly lower before the evening snack (10.2 ± 1.0 mmolll during guar gum, 12.5 ± 1.3 mmolll during placebo, P < 0.05) and 1 h after it (10.3 ± 0.9 and 12.9 ± 1.1 mmolll, respectively, P < 0.01).
Plasma Insulin
Plasma insulin concentration after a 12-h fast at the end of the three-month period was 10.9 ± 3.0 mUll in patients on guar gum and 11.0 ± 2.6 mUll in the 
Serum and Lipoprotein Lipids
Before the study, the mean fasting serum cholesterol concentration was 6.73 ± 0.58 mmolll (range 5.30-8.98 mmolll). Three of the subjects had a serum cholesterol level exceeding 8 mmolil. The mean triglyceride concentration was 1.62 ± 0.51 mmolll (range 0.78-4.60 mmolll). Two of the subjects had a triglyceride level that exceeded 2 mmolil. The patient with the highest serum triglyceride level had to be excluded because of incomplete samples.
The mean serum cholesterol concentration was significantly lower during the guar gum period. This was due to a significantly lower LDL-cholesterol level (Table 2 ). There was no difference in serum HDL-cholesterol concentration, but the LDLlHDLcholesterol ratio was lower in the guar gum period (4.09 ± 0.65) than in the placebo period (4.64 ± 0.59). This difference was not statistically significant. There was no difference in the triglyceride concentrations of whole serum and in lipoprotein fractions (Table 2) . placebo group. Pre-and post-prandial plasma insulin levels were the same in both groups (Fig. 1) . However, the two subjects who were on dietary therapy only, showed a clear reduction in plasma insulin levels during the guar gum period. During the placebo period, peak post-prandial plasma insulin levels were 91.5 and 90.0 mUll at 30 and 15 min after the meal. During the guar gum period, the peak concentrations were 48.7 and 40.7 mUll and occurred later, at 60 and 45 min after the meal. 
Serum and Urinary Calcium
The serum calcium concentration was the same during supplementation with guar gum (2.42 ± 0.03 mmolll) and with placebo (2.38 ± 0.03 mmolll), but excretion of urinary calcium was significantly lower (2.64 ± 0.67 mmo1l24 h) during the guar gum period when compared with the placebo period 
Side-Effects
Two of the 11 subjects who started the study stopped guar gum treatment because of meteorism and abdominal discomfort. Other side-effects were mild but flatulence was universally reported with guar gum.
Discussion
In this study, dietary supplementation with guar gum induced a significant and sustained reduction in basal hyperglycaemia, with only a slight reduction in the post-prandial increment of blood glucose. The effect is similar to that found during a high-carbohydrate diet containing natural fibre [4] and differs from the findings of studies on the post-prandial effects of guar-containing test meals [1, 2] . Most subjects in the present study were hyperglycaemic despite treatment with oral agents. The change in mean blood glucose concentration was rather small during the guar gum period, whereas the diabetic control clearly deteriorated during the placebo period. One possible explanation for this finding could be seasonal variation in the composition of the diet. This study was started during late summer and autumn, when domestic vegetables and legumes are easily available in Finland, and it was completed in the winter in different conditions.
In studies on high-carbohydrate, high-fibre diets [3, 4] , the proportion of carbohydrates has been altered in addition to the content of dietary fibre. In the present study, only the amount of guar gum in the diet was changed. The results are very similar to those of a recent study in which large amounts of fibre from natural sources were used under metabolic ward conditions [6] . The results are not explained by changes in the bodyweight of the subjects. As it was possible to maintain a lower blood glucose level despite similar plasma insulin levels, sensitivity to insulin was increased. This was most marked in the two subjects who had relatively mild diabetes and who received no oral hypoglycaemic agents. In addition to reduced plasma insulin levels, reduced plasma glucagon and GIP concentrations have been found during dietary supplementation with fibre [5, 15] . The long-term effects may be different from the acute effect on gastrointestinal motility and postprandial blood glucose response, but the smaller post-prandial excursions of blood glucose may also result in metabolic changes leading to improved glucose control [11] . Dietary factors, including fibre, may also modify the binding of insulin to receptors [16] .
The preparations were consumed as one bolus at the beginning of the main meals. The importance of proper timing and mixing of the guar gum supplements have been stressed [17] . Our results suggest it is not necessary to premix the fibre with every carbohydrate portion in order to improve long-term diabetic control. Furthermore, providing guar is taken with the main meals, it is not necessary to administer it with snacks to achieve the favourable A. Aro et al.: Guar Gum in Type 2 Diabetes effects on blood glucose and serum LDL-cholesterol levels.
The poor palatability of guar gum preparations has presented many difficulties [18] . The only acceptable way of administering guar gum in long-term practice has been in the form of guar crispbread [9, 10, 19] which, however, limits the possibilities of utilizing dietary carbohydrates from other sources and thus alters the normal diet of the diabetics. A more acceptable way of dietary supplementation with guar gum is addition as slow-gelling preparation.
Side-effects from guar gum were mostly mild, but two subjects could not finish the study, suggesting that this therapy would not suit all diabetics.
The reduction in serum total and LDL-cholesterol concentration, probably caused by increased excretion of cholesterol in bile acids [20] , has been described in hypercholesterolaemic subjects [19] . Reduction in the LDLlHDL-cholesterol ratio probably reduces the risk of coronary heart disease [21] .
The reduced urinary excretion of calcium is partly explained by the reduced glucose excretion [22] , but it is possible that some of this is due to impaired calcium absorption from the gut.
We conclude that dietary supplementation with guar gum improves diabetic control in Type 2 diabetes. It also decreases serum LDL-cholesterol concentration without affecting the level of HDL-cholesterol, thus inducing a favourable change in the serum lipoprotein pattern. The results give indirect support to the theories which link the incidence of diabetes to the fibre content of the diet [23] and emphasize the role of abundant fibre intake in the treatment, and possibly also in the prevention, of Type 2 diabetes. Due to the combined favourable effects on glucose and lipid metabolism, dietary enrichment with guar gum appears to be a useful adjunct to the therapy of Type 2 diabetes, especially in the presence of coexistent hypercholesterolaemia.
